United Services Automobile Association’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-63,944
Closed -$343K 1302
2016
Q1
$343K Sell
63,944
-17,800
-22% -$112K ﹤0.01% 1228
2015
Q4
$970K Buy
81,744
+1,070
+1% +$12.2K ﹤0.01% 1086
2015
Q3
$662K Sell
80,674
-2,720
-3% -$31.4K ﹤0.01% 1143
2015
Q2
$1.16M Buy
83,394
+2,520
+3% +$46.2K ﹤0.01% 1100
2015
Q1
$1.94M Buy
80,874
+33,374
+70% +$751K 0.01% 975
2014
Q4
$782K Buy
+47,500
New +$548K ﹤0.01% 1137

Other funds holding DRNA

United Services Automobile Association's DRNA Position: Q2 2016 in Review

United Services Automobile Association sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q2 2016, closing a stake of 63,944 shares — an estimated $343K sold.

United Services Automobile Association first reported a position in DRNA in Q4 2014 and held it in 6 quarters. The position peaked at $1.94M in Q1 2015. 53 funds tracked by Wall St. Rank hold DRNA as of Q2 2016.

  • United Services Automobile Association reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • United Services Automobile Association sold 63,944 Dicerna Pharmaceuticals, Inc. shares in Q2 2016, an estimated $343K.
  • United Services Automobile Association first reported a position in Dicerna Pharmaceuticals, Inc. in Q4 2014 and held it in 6 quarters.
  • United Services Automobile Association's Dicerna Pharmaceuticals, Inc. position peaked at $1.94M in Q1 2015.
  • 53 funds tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q2 2016.

Based on United Services Automobile Association's 13F filing for Q2 2016, filed 11 Aug 2016.